Disclosures

1. What Klarovel is (and is not)

Klarovel is a global peptide intelligence platform. We publish research-grade educational content on peptides, protocols, and longevity science, and we connect users to a vetted network of third-party distributors for the supply of high-quality peptides for research purposes only.

Klarovel is not a pharmacy, not a clinic, not a medical practice, and not a healthcare provider. We do not manufacture, hold, or ship peptides ourselves.

2. Who this content is for

Our content is written for an informed, technically literate audience: researchers, clinicians, biohackers, longevity-curious readers, and others who want to understand peptide science at primary-source depth. We assume the reader is capable of judging the relevance and limits of preclinical and clinical data.

3. Editorial and medical review

Every long-form post is reviewed before publication by the Klarovel Medical Advisory Board, an independent editorial review function inside Klarovel that checks each piece for: claim sourcing against peer-reviewed literature; dose statements against the published peptide research catalogue; regulatory accuracy where the post touches jurisdiction-specific rules; and tone consistent with our wellness-information posture.

Each post carries the date of its most recent review. When regulatory facts, study results, or pricing change materially, the affected post is reviewed again and the review date updated.

4. Affiliate disclosure

Klarovel earns a commission on transactions completed through links to our vetted distributor network. The decision to feature a distributor is made on quality, third-party testing, supply consistency, and regulatory posture, not on commission rate.

Editorial coverage of a peptide is not contingent on whether a distributor in our network supplies it. We write about peptides whose distributors we do not link to, and we will continue to do so where the topic warrants coverage.

This disclosure satisfies the United States Federal Trade Commission's 16 CFR Part 255 endorsement guides, the European Union's Unfair Commercial Practices Directive (2005/29/EC), and the Norwegian Forbrukertilsynet's guidance on hidden marketing.

5. No medical advice

Nothing on Klarovel is medical advice, diagnosis, or treatment. Reading our content does not establish any clinician-patient relationship. Always consult a qualified healthcare professional before starting, stopping, or modifying any peptide regimen, especially if you are pregnant, nursing, have a medical condition, or are taking prescription medication.

6. Research purposes only

Peptides supplied through the distributor network we link to are provided for research purposes only. Klarovel does not direct, supervise, or endorse any in vivo human use. Local laws on the possession, importation, and use of peptides vary widely by jurisdiction; readers are responsible for understanding and complying with the rules that apply where they live.

7. Update and freshness policy

Posts are scheduled for refresh on a 90-day cycle for top performers and a 180-day cycle by default. Refreshes can also be triggered out-of-cycle by: regulatory changes, new peer-reviewed studies, recall or safety notices, or significant pricing shifts in the distributor network.

Each post surfaces both its original publication date and its most recent review date so readers can judge freshness independently of our schedule.

8. Corrections

We correct material errors quickly. If you spot one, write to editorial at klarovel dot com with the post URL and a citation to the corrected fact. Corrections that change a load-bearing claim are noted at the foot of the post.

9. Contact

Editorial questions: editorial at klarovel dot com. Privacy: privacy policy. Terms: terms of use.